AstraZeneca's combo drug for lung cancer succeeds in late-stage trial

AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a late-stage study, sending its shares up 2%.

from Reuters: Health News https://ift.tt/2MSObv5
via IFTTT